Novartis confirms unconstrained supply for Pluvicto® and continues to significantly expand the number of treatment centers
Novartis confirms unconstrained supply for Pluvicto® and continues to significantly expand the number of treatment centers
arcticnovartis
- US FDA has classified drug shortage status as resolved1
- Novartis capacity to produce Pluvicto will continue to grow with anticipated expansions to the manufacturing network in the US and globally
- More than 200 centers are actively ordering doses of Pluvicto for patients in need, with plans to onboard approximately 130 more